Home / Research / Product codes / JWY Medical-device intelligence
JWY: Manual Antimicrobial Susceptibility Test Systems FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code JWY
FDA device name Manual Antimicrobial Susceptibility Test Systems
Device class 2
Regulation number 866.1640
Medical specialty Microbiology
Review panel MI The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.
Explore microbiology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 1 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 2 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 519 matching records Device / record Company in FDA record Source Source date ETEST CLINICAL ETEST VANCOMYCIN VA M100 US, CATALOG 423788 Z-0860-2023 · JWYBiomerieux Inc Recall Jan 4, 2023FDA classification date Thermo SCIENTIFIC Sensititre Plate, GN4F, Gram Negative IVD AST Z-0327-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre GN6F, Gram Negative IVD AST Z-0328-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre GN7F, Gram Negative IVD AST Z-0329-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre HPB1, Gram Negative IVD AST Z-0330-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre CMC5VGNF, Gram Negative IVD AST Z-0331-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre CMC7AFLF, Gram Negative IVD AST Z-0332-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre MDRGN3F, Gram Negative IVD AST Z-0333-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD AST Z-0334-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo SCIENTIFIC, Sensititre STP7F, Gram Negative IVD AST Z-0335-2023 · JWYRemel Inc Recall Dec 8, 2022FDA classification date Thermo Scientific Sensititre Gram Negative Susceptibility Testing Plate, IVD format Z-0722-2022 · JWYRemel Inc Recall Mar 4, 2022FDA record creation date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 ug/ml K203741 · JWYThermo Fisher Scientific 510(k) Dec 20, 2021FDA decision date ETEST Fosfomycin (FO) (0.032-512 µg/mL) K210757 · JWYBiomerieux S.A. 510(k) Nov 12, 2021FDA decision date MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL K211672 · JWYLiofilchem s.r.l. 510(k) Oct 20, 2021FDA decision date ETEST IMIPENEM RELEBACTAM. in vitro diagnostic Z-2226-2021 · JWYBiomerieux Inc Recall Aug 6, 2021FDA record creation date Sensititre 20-24 hour Haemophilus influenzae /Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dtest (containing erythromyci… K202612 · JWYThermo Fisher Scientific 510(k) Jul 23, 2021FDA decision date MicroScan MICroSTREP plus Panels with Tetracycline (0.06-16 µg/mL) K202423 · JWYBeckman Coulter, Inc. 510(k) May 18, 2021FDA decision date ETEST Plazomicin (PLZ) (0.016-256 µg/mL) K200512 · JWYBiomérieux SA 510(k) May 7, 2020FDA decision date MTS Lefamulin 0.016- 256 µg/mL K200308 · JWYLiofilchem S. R. 1. 510(k) Apr 6, 2020FDA decision date MTS Omadacycline 0.002 - 32 ug/mL K200180 · JWYLiofilchem s.r.l. 510(k) Mar 20, 2020FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 µg/ml K193538 · JWYThermo Fisher Scientific 510(k) Mar 12, 2020FDA decision date Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint, Susceptibility System with Lefamulin in the dilution ran… K193024 · JWYThermo Fisher Scientific 510(k) Jan 8, 2020FDA decision date ETEST Delafloxacin (DFX) (0.002-32 µg/mL) K192738 · JWYBiomerieux S.A. 510(k) Nov 26, 2019FDA decision date MicroScan Dried Gram Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32ug/mL) K192355 · JWYBeckman Coulter, Inc. 510(k) Nov 14, 2019FDA decision date Sensititre 18-24 Hour MIC or Breakpoint Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/ml K192729 · JWYThermo Fisher Scientific 510(k) Nov 6, 2019FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗